Suppr超能文献

d-葡萄糖共轭苯并噻唑-噻唑烷-4-酮杂化物:作为多靶点抗阿尔茨海默病化合物的设计与合成

d‑Glucose-Conjugated Benzo[]thiazole-thiazolidin-4-one Hybrids: Design and Synthesis as Multitarget Anti-Alzheimer Compounds.

作者信息

Thanh Nguyen Dinh, Toan Vu Ngoc, Hai Do Son, Tri Nguyen Minh, Toan Duong Ngoc, Trang Vu Minh

机构信息

Faculty of Chemistry, VNU University of Science (Vietnam National University, Ha Noi), 19 Le Thanh Tong, Hoan Kiem, Ha Noi 10000, Viet Nam.

Institute of Science and Technology, Ministry of Public Security of Vietnam, 47 Pham Van Dong, Cau Giay, Ha Noi 10000, Viet Nam.

出版信息

ACS Med Chem Lett. 2025 May 5;16(6):1024-1030. doi: 10.1021/acsmedchemlett.5c00064. eCollection 2025 Jun 12.

Abstract

A new series of d-glucose-conjugated 2,3-thiazoline-benzo-[]-thiazole hybrid compounds - were synthesized from reaction of the corresponding thioureas - and ethyl bromoacetate in the presence of sodium acetate in chloroform. The evaluations for anti-Alzheimer activity showed that some compounds exhibited remarkable inhibitory activity against AChE and BChE as well as against MAO-A and MAO-B enzymes. The orders of inhibition for each enzyme of these compounds were as follows: > (against AChE), > (against BChE), > > (against MAO-A), and > (against MAO-B). Compound was an inhibitor of interest due to its potent or good activity against the two studied enzymes BChE and MAO-B, respectively. Compounds (against AChE) and (against (BChE) had a competitive type with constants of 16.93 and 17.09 nM, respectively. The most potential compounds , , and were not cytotoxic on 3T3 cells and had high levels of safety.

摘要

一系列新的d-葡萄糖共轭的2,3-噻唑啉-苯并[]-噻唑杂化化合物——由相应的硫脲与溴乙酸乙酯在醋酸钠存在下于氯仿中反应合成。抗阿尔茨海默病活性评估表明,一些化合物对乙酰胆碱酯酶(AChE)、丁酰胆碱酯酶(BChE)以及单胺氧化酶A(MAO-A)和单胺氧化酶B(MAO-B)均表现出显著的抑制活性。这些化合物对每种酶的抑制顺序如下: > (针对AChE), > (针对BChE), > > (针对MAO-A),以及 > (针对MAO-B)。化合物 因其分别对所研究的两种酶BChE和MAO-B具有强效或良好活性而成为有意义的抑制剂。化合物 (针对AChE)和 (针对BChE)具有竞争类型,其 常数分别为16.93和17.09 nM。最具潜力的化合物 、 和 对3T3细胞无细胞毒性且具有高安全性。

相似文献

1
d‑Glucose-Conjugated Benzo[]thiazole-thiazolidin-4-one Hybrids: Design and Synthesis as Multitarget Anti-Alzheimer Compounds.
ACS Med Chem Lett. 2025 May 5;16(6):1024-1030. doi: 10.1021/acsmedchemlett.5c00064. eCollection 2025 Jun 12.
3
Rhodanine-pyridinium derivatives as a new category of cholinesterase inhibitors: Design, synthesis, in vitro and in silico enzymatic evaluations.
Int J Biol Macromol. 2025 Aug;320(Pt 1):145731. doi: 10.1016/j.ijbiomac.2025.145731. Epub 2025 Jul 3.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.
Cochrane Database Syst Rev. 2017 Jan 14;1(1):CD011279. doi: 10.1002/14651858.CD011279.pub2.

本文引用的文献

1
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier.
Ageing Res Rev. 2024 Nov;101:102481. doi: 10.1016/j.arr.2024.102481. Epub 2024 Sep 3.
2
The therapeutic value of thiazole and thiazolidine derivatives in Alzheimer's disease: a systematic literature review.
Res Pharm Sci. 2024 Feb 6;19(1):1-12. doi: 10.4103/1735-5362.394816. eCollection 2024 Feb.
4
Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification.
Int J Biol Macromol. 2023 Nov 1;251:126158. doi: 10.1016/j.ijbiomac.2023.126158. Epub 2023 Aug 6.
5
6
Biomarkers in Alzheimer's disease.
Adv Lab Med. 2020 Nov 23;2(1):27-50. doi: 10.1515/almed-2020-0090. eCollection 2021 Mar.
7
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics.
Cancer Metastasis Rev. 2023 Sep;42(3):847-889. doi: 10.1007/s10555-023-10106-1. Epub 2023 May 19.
8
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease.
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2175821. doi: 10.1080/14756366.2023.2175821.
9
Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease.
RSC Adv. 2022 Aug 19;12(36):23626-23636. doi: 10.1039/d2ra03803j. eCollection 2022 Aug 16.
10
Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies.
Eur J Med Chem. 2022 Nov 15;242:114655. doi: 10.1016/j.ejmech.2022.114655. Epub 2022 Aug 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验